Skip to content

COMPARATIVE EVALUATION OF IMPLANT STABILITY AND ALVEOLAR BONE STATUS AFTER TREATMENT OF IMPLANT SITE WITH ZOLENDRONIC ACID- A CLINICAL TRIAL.

COMPARATIVE EVALUATION OF IMPLANT STABILITY AND PERI IMPLANT BONE STATUS AFTER TREATMENT OF OSTEOTOMY SITE WITH ZOLENDRONIC ACID â?? A DOUBLE BLINDED, SPLIT MOUTH RANDOMIZED CLINICAL TRIAL.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/048136
Enrollment
58
Registered
2022-12-15
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K039- Disease of hard tissues of teeth,unspecified

Interventions

Intervention1: 1ml of 0.2mg Zolendronic acid: Topical application 1ml of 0.2mg zolendronic acid at the implant osteotomy site for 2 min at the time of implant placement Control Intervention1: 1ml of 0

Sponsors

Government Dental College Hospital Mumbai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All patients indicated for dental implants in 2 stage technique. 2. Patients who are willing to participate in the study. 3.Patients, having two teeth missing in same or opposite either arch

Exclusion criteria

Exclusion criteria: 1. Patients with adjacent edentulous space. 2. All patients who are contraindicated for dental implants. 3. Patients having maxilla-mandibular space discrepancies. 4. Patients with gross malocclusion. 5. Patients who have undergone periodontal surgical treatment within the last 6 months

Design outcomes

Secondary

MeasureTime frame
NilTimepoint: Nil

Primary

MeasureTime frame
1.To measure the implant stability quotient by resonance frequency analyser. 2.To radiographically measure the amount of bone bone around implant site.Timepoint: At Baseline, at 3 Months, 4 Months

Countries

India

Contacts

Public ContactDr Mrimingsi Kri

Government Dental College and Hospital Mumbai

jaylandge39@gmail.com8591449573

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026